Farah Mazahreh

Researcher

Last publication 2026 Last refreshed 2026-05-16

faculty

3 h-index 20 pubs 150 cited

Research Areas

OverviewAI-generated summary

Farah Mazahreh's research focuses on the clinical management of various health conditions, with a significant emphasis on oncological treatments and patient outcomes. Her work includes investigations into the risks associated with specific therapeutic agents, such as the incidence of infections linked to bispecific antibodies in patients with multiple myeloma. Mazahreh has also explored the impact of treatment interventions, including high-dose steroid use in patients undergoing immunotherapy for renal cell carcinoma. Her research extends to patient safety, examining adverse events like venous thromboembolism during anticoagulation therapy.

Beyond direct patient care, Mazahreh has contributed to understanding factors influencing career choices within medicine, specifically for oncologists, and has addressed critical issues such as visa constraints for international medical professionals. Her scholarly output, marked by a h-index of 3 and over 140 citations, reflects active engagement in the medical research community. She has collaborated on multiple publications with researchers at the University of Arkansas for Medical Sciences, including Liyan Mazahreh and A. Mazin Safar.

Metrics

h-index: 3
Publications: 20
Citations: 150

Selected Publications

Abstract 5582: Interrogating the K-ras/p53 transcriptional readout for synthetic lethality applications (2025)

DOI OpenAlex
Ongoing Radiographic Response for Over 20 Months in Metastatic Cancer Without Continued Immune Checkpoint Inhibitor (ICI) Dosing (2025)

DOI OpenAlex
Tumor Response to Immune-Oncology Therapy Despite High-Dose Steroid Intervention in a Patient With Papillary Renal Cell Carcinoma and Immune-Related Myasthenia Gravis (2025)

2 citations DOI OpenAlex
Abstract 3856: Nodal metastasis as an immune indicator in cancer (ca) therapy (2024)

DOI OpenAlex
Abstract 1177: The chronology of immune-related adverse events (irAEs)-mechanistic implications (2024)

DOI OpenAlex
Abstract 1567: Honing in on the metastasis machinery (2024)

DOI OpenAlex
Risk of infections associated with the use of bispecific antibodies in multiple myeloma: a pooled analysis (2023)

114 citations DOI OpenAlex
Risk of Infections Associated with the Use of Bispecific Antibodies in Multiple Myeloma: A Pooled Analysis (2022)

16 citations DOI OpenAlex
“Ain’t She a Bute?”: The Importance of Proper History Taking in a Case of Inappropriate Use of Horse NSAID in a Human (2021)

3 citations DOI OpenAlex
Venous Thromboembolism While on Anticoagulation With Apixaban (2021)

2 citations DOI OpenAlex